Clinical Trial Update: Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease [Phase 2]

View source ↗

Summary

Phase 2 trial comparing sirolimus (rapamycin) against corticosteroids for thyroid-associated ophthalmopathy, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Ophthalmopathy

Drugs mentioned

• Corticosteroids (corticosteroids)
• Rapamycin (Sirolimus) (sirolimus)

Snippet

Sponsor: Haukeland University Hospital | Conditions: Thyroid-Associated Ophthalmopathy | Phase 2 | Status: RECRUITING